BlackRock Health Sciences Trust Gross Profit

BlackRock Health Sciences Trust posts a gross profit of $54M as of December 2025. That compares with $33M in the prior-year period — up 63.2% year over year. That is below the sector sector average of $720M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BlackRock Health Sciences Trust's gross profit was $33M. The latest reading is $54M — a 63.2% year-over-year increase (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a gross profit near $720M is typical. BlackRock Health Sciences Trust's $54M is lower that level. That is roughly 92.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Gross Profit is one piece of BlackRock Health Sciences Trust's financial statement story. At $54M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BME's gross profit usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $720M), and (3) consistency with growth and profitability. This page covers the first two; BlackRock Health Sciences Trust's other metric pages and overview cover the third.